PPT-Promoting Adherence and Retention in ARV-based Prevention

Dr Seema Sahay PhD Division of Social and Behavioral Research National AIDS Research Institute Indian Council of Medical Research Pune India Overview Defining and measuring adherence Issues around adherence. Module 1: . Basic definitions. www.icad-cisd.com. Objectives . This workshop will:. Increase the capacity of media representatives to report on NPT trials with accuracy and sensitivity. Build skills amongst community-based organizations to critically analyze media discourse about HIV prevention trials. Bernard Vrijens, PhD. Chief Science Officer, MWV Healthcare. Associate Professor of Biostatistics . University of Liège, Belgium. Adherence is key to therapeutic success. 2. Effective. Disease. Management. Jennifer Gatsi Mallet. Namibia Women’s Health Network / ICW. Community Mobilization. The. process of engaging communities to identify community priorities, resources, needs and solutions. .. . Using these resources . Reasons why patients do not adhere. Measuring adherence and non adherence. Improving adherence. Reasons for non-adherence: cognitive rational non-adherence. Adherence is all about being conscientious in following medical advice. . Doyle M. Cummings, PharmD, FCP, FCCP. Professor of Family Medicine and Public Health. East Carolina University, Brody School of Medicine. Greenville, North Carolina. . [Residency educators may . adapt and use . Angelica Lindsey-Ali & Calicia White. Ebony House Inc.. Objectives. By the end of this section, participants should be able to. : . Understand the difference between cultural humility and cultural competence. B. Wamuti. , J. Odoyo, B. Rono, C. Cohen, E. Bukusi. . Kenya Medical Research Institute. University of Washington. University of California, San Franscisco . . Adherence crucial for success of any clinical drug trial and/or treatment. Hypertension. A Major Public Health Crisis. 20-Year Trends in Hypertension in the US. 1988–2008. Hypertension. African Americans. Contrasts in Goal BP Recommendations. Systolic Blood Pressure Intervention Trial (SPRINT). Cameroon Perspectives . IAS, Paris 23 July, . 2017. Pr. . Sinata. . Koulla-Shiro. 1. HIV . EPIDEMIC TRENDS IN CAMEROON. (2000 – 2016). HIV Prevalence. General population: 3,8% (Spectrum 2016). Pregnant women: 1.7% (N) to 7% (South/East). relevance and options for the future. B. Dongmo Nguimfack. AMDS . TCO Unit/HIV, WHO. . . What is AMDS. The AMDS is a network of technical partner organisations that work to support countries in procurement and supply management of HIV commodities. The secretariat of this network is housed in WHO/HIV Department. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents . April 2015. AETC . NCRC . Slide Set. 2. July 2016. www.aidsetc.org. About This Presentation. These slides were developed using the April 2015 . 1 City in Addis Ababa A Proposal on the CHBC Project Lisan Atnafe: CHBC Project Officer Anley Haile : MNCH project advisor February 2013 2 Acronyms AIDS Acquired Immunodeficiency Syndrome AMREF Afr EPF Position Paper March 2015 2 Adherence and Concordance EPF position paper , March 2015 Contents 1 Introduction ................................ ................................ .................... PLHIV [1]. . Failure . to maintain adherence to ART is causally associated with the progression of HIV to AIDS, increased risk of opportunistic infections, and mortality with lowering of quality of .